The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial.
about
Microbial translocation in chronic liver diseasesImmunomodulating effects of antibiotics used in the prophylaxis of bacterial infections in advanced cirrhosisEndothelial dysfunction in cirrhosis: Role of inflammation and oxidative stressRethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertensionHepatic encephalopathy in acute-on-chronic liver failure.Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease.Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia.Probiotics (VSL#3) prevent endothelial dysfunction in rats with portal hypertension: role of the angiotensin systemBacterial load and cytokine profile in patients with cirrhosis following therapy with proton pump inhibitors: a prospective cohort study.The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS).The hepatoadrenal syndrome: a common yet unrecognized clinical condition.Alcoholic hepatitis: current challenges and future directions.Infection, coagulation, and variceal bleeding in cirrhosis.Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential.Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.Review article: the therapeutic and prognostic benefit of portal pressure reduction in cirrhosis.Targeting the gut-liver axis in cirrhosis: antibiotics and non-selective β-blockers.The course of type 1 hepato-renal syndrome post liver transplantation.Recent and currently emerging medical treatment options for the treatment of alcoholic hepatitis.A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection.Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis.Bacterial translocation (BT) in cirrhosis.Adrenal-exhaustion syndrome in patients with liver disease.Cardiac and vascular changes in cirrhosis: pathogenic mechanisms.Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients.Toll-like receptors as targets in chronic liver diseases.The role of intestinal endotoxin in liver injury: a long and evolving history.The effects of cefazolin on cirrhotic patients with acute variceal hemorrhage after endoscopic interventions.Hepatorenal syndrome in the intensive care unit.New therapeutic paradigm for patients with cirrhosis.The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension.The emerging roles of microvesicles in liver diseases.Oral probiotic VSL#3 attenuates the circulatory disturbances of patients with cirrhosis and ascites.Protein array technology to investigate cytokine production by monocytes from patients with advanced alcoholic cirrhosis: An ex vivo pilot study.Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management.Novel treatment options for portal hypertension.Rifaximin has minor effects on bacterial composition, inflammation and bacterial translocation in cirrhosis; A randomized trial.Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study.Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study.Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis.
P2860
Q21284997-C76F729F-4916-4A55-9D91-A03657B20A67Q26778064-D31D3231-653E-46C0-8822-B61DEBC6894AQ27023122-2BE2197D-01A0-4937-80CD-A28EBFD1CCCFQ28069136-874E4B23-D9E5-484D-B416-ABDC043F1B58Q30959584-38DE3E14-9771-40A3-B945-38914B8FEA8CQ33379412-30D72458-A791-436C-9391-FC728310B8F8Q33398338-177A813C-43A4-4D50-95A3-2B1615D9B375Q33618266-8A2C5193-899D-4E05-9540-3F0D3ED40391Q33822986-E884C6F0-99F6-4E02-B47B-B3F0335C57A2Q34042078-9997A093-4360-4863-B866-F79311BA3117Q34340237-AB089066-D4C9-4D4B-B32F-1CE3B15A4CD6Q34354286-F56C8FB8-B3C9-4B65-8562-3FB6E07AB266Q34400962-623B7A8C-78EF-4748-8F84-9627E3E1E7DAQ34557101-9B11E5E1-58CC-4B11-BCCA-A3C223310FC0Q34647371-7AF17540-2812-4526-8D31-5C4C07CA5168Q34796104-F38CBEDE-DF42-454B-BAFC-CFC82E9935A5Q34861969-18A2BB6D-02DC-41E2-A699-FDE320232EDEQ35160366-35B7F396-5FE2-4A78-B141-04D46661B976Q35233527-60C189E3-DDCF-4731-AB7E-25F5E86318EEQ35544658-9C1305BD-3C35-4600-ABA5-CA409DE3CFAAQ35651447-D348692F-E6E6-448D-8299-13140454D83AQ36050434-18AAD020-8F31-4C82-8429-FC43915A7C64Q36376030-B5C2E9FB-F994-450A-B25E-9C434B8BB0DDQ36415452-1C1983E6-E1A8-4798-8F9B-99E4887E5B37Q36666840-757FA574-5FB5-4823-AFF2-0A17BD505E6DQ37469924-D4042A86-1663-40E9-82CE-228F0499ECF1Q37796722-E9933197-1D28-488C-9BBC-A64FE2CA0F97Q37855600-57C6B2C4-7F46-41C6-9A61-CBBDE600D06EQ37920945-0F9F802A-0D2A-494D-8FD4-BD4113FC15AAQ38021413-263E3D9D-7E31-425B-83D7-03F3B375E43AQ38074434-6C6AE625-3124-4565-8BA0-7F4B59B741A4Q38184831-34A2B702-B53D-43D1-97F9-62DA21A665B8Q38308253-62DE51A0-F04E-47FD-AA21-6EE3B2361106Q38510052-73299436-C9B8-4829-876A-413F48340F6DQ38635623-1209D390-CBDF-4610-AB55-34EC55384E78Q38680437-57174619-4C74-405B-9CCB-A448A0C12DF1Q38696806-86AFE708-0D6B-46D9-8026-5B5B39C2A413Q38708565-FE4FD32C-90F5-42EC-BA8C-44A51DFC4BD3Q38882409-A059C852-C0AA-44B6-B5B1-C41CF8280F85Q39365144-5B4EBB9D-BAFD-4111-A08A-8E755A7BED8A
P2860
The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
The effect of selective intest ...... cirrhosis. A randomized trial.
@en
The effect of selective intest ...... cirrhosis. A randomized trial.
@nl
type
label
The effect of selective intest ...... cirrhosis. A randomized trial.
@en
The effect of selective intest ...... cirrhosis. A randomized trial.
@nl
prefLabel
The effect of selective intest ...... cirrhosis. A randomized trial.
@en
The effect of selective intest ...... cirrhosis. A randomized trial.
@nl
P2093
P1476
The effect of selective intest ...... cirrhosis. A randomized trial.
@en
P2093
Brindhesha Rasaratnam
David Kaye
Francis Dudley
Garry Jennings
Jaye Chin-Dusting
P304
P356
10.7326/0003-4819-139-3-200308050-00008
P407
P577
2003-08-01T00:00:00Z